Optimal design of thedes based on perillyl alcohol and ibuprofen
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/121384 |
Resumo: | PTDC/BBB-490 EBB/1676/2014 PTDC/CTM-CTM/29813/2017 SFHR/BD/143902/2019 SFRH/BPD/116779/2016 |
id |
RCAP_ef30cb2c5c727d29421106b4907d4baa |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/121384 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Optimal design of thedes based on perillyl alcohol and ibuprofenActive pharmaceutical ingredientsAnticancer propertiesAntimicrobial propertiesGreen chemistryNatural moleculesTherapeutic deep eutectic systemsPharmaceutical ScienceSDG 3 - Good Health and Well-beingPTDC/BBB-490 EBB/1676/2014 PTDC/CTM-CTM/29813/2017 SFHR/BD/143902/2019 SFRH/BPD/116779/2016Therapeutic deep eutectic systems (THEDES) have dramatically expanded their popularity in the pharmaceutical field due to their ability to increase active pharmaceutical ingredients (APIs) bioavailability. However, their biological performance has not yet been carefully scrutinized. Herein, THEDES based on the binary mixture of perillyl alcohol (POH) and ibuprofen (IBU) were prepared using different molar ratios. Our comprehensive strategy includes the characterization of their thermal and structural behavior to identify the molar ratios that successfully form deep eutectic systems. The in vitro solubility of the different systems prepared has demonstrated that, unlike other reported examples, the presence of the terpene did not affect the solubility of the anti-inflammatory agent in a physiological simulated media. The biological performance of the systems was studied in terms of their antimicrobial activity against a wide panel of microorganisms. The examined THEDES showed relevant antimicrobial activity against all tested microbial strains, with the exception of P. aeruginosa. A synergistic effect from the combination of POH and IBU as a eutectic system was verified. Furthermore, the cytotoxic profile of these eutectic systems towards colorectal cancer (CRC) in vitro cell models was also evaluated. The results provide the indication that the cell viability varies in a dose-dependent manner, with a selective THEDES action towards CRC cells. With tunable bioactivities in a ratio-dependent manner, THEDES enhanced the antimicrobial and anticancer properties, representing a possible alternative to conventional therapies. Therefore, this study provides foreseeable indications about the utility of THEDES based on POH and IBU as strong candidates for novel active pharmaceutical systems.DQ - Departamento de QuímicaLAQV@REQUIMTERUNSilva, EduardoOliveira, FilipeSilva, Joana M.Matias, AnaReis, Rui L.Duarte, Ana Rita C.2021-07-20T22:20:13Z2020-11-202020-11-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article17application/pdfhttp://hdl.handle.net/10362/121384eng1999-4923PURE: 32670749https://doi.org/10.3390/pharmaceutics12111121info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:03:42Zoai:run.unl.pt:10362/121384Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:44:35.792124Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
title |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
spellingShingle |
Optimal design of thedes based on perillyl alcohol and ibuprofen Silva, Eduardo Active pharmaceutical ingredients Anticancer properties Antimicrobial properties Green chemistry Natural molecules Therapeutic deep eutectic systems Pharmaceutical Science SDG 3 - Good Health and Well-being |
title_short |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
title_full |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
title_fullStr |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
title_full_unstemmed |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
title_sort |
Optimal design of thedes based on perillyl alcohol and ibuprofen |
author |
Silva, Eduardo |
author_facet |
Silva, Eduardo Oliveira, Filipe Silva, Joana M. Matias, Ana Reis, Rui L. Duarte, Ana Rita C. |
author_role |
author |
author2 |
Oliveira, Filipe Silva, Joana M. Matias, Ana Reis, Rui L. Duarte, Ana Rita C. |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
DQ - Departamento de Química LAQV@REQUIMTE RUN |
dc.contributor.author.fl_str_mv |
Silva, Eduardo Oliveira, Filipe Silva, Joana M. Matias, Ana Reis, Rui L. Duarte, Ana Rita C. |
dc.subject.por.fl_str_mv |
Active pharmaceutical ingredients Anticancer properties Antimicrobial properties Green chemistry Natural molecules Therapeutic deep eutectic systems Pharmaceutical Science SDG 3 - Good Health and Well-being |
topic |
Active pharmaceutical ingredients Anticancer properties Antimicrobial properties Green chemistry Natural molecules Therapeutic deep eutectic systems Pharmaceutical Science SDG 3 - Good Health and Well-being |
description |
PTDC/BBB-490 EBB/1676/2014 PTDC/CTM-CTM/29813/2017 SFHR/BD/143902/2019 SFRH/BPD/116779/2016 |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-11-20 2020-11-20T00:00:00Z 2021-07-20T22:20:13Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/121384 |
url |
http://hdl.handle.net/10362/121384 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1999-4923 PURE: 32670749 https://doi.org/10.3390/pharmaceutics12111121 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
17 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138053323751424 |